Rhabdomyosarcoma in Adults: New Perspectives on Therapy

Catalina Ruiz-Mesa, John M. Goldberg, Alvaro J. Coronado Munoz, Sarah N. Dumont, Jonathan Trent

Research output: Contribution to journalArticle

19 Scopus citations

Abstract

Rhabdomyosarcoma (RMS) is well known as a pediatric disease. Most of the knowledge, like biology, genetics, and treatments of this disease, comes from studies done in that age group. The two subtypes of RMS, embryonic RMS and alveolar RMS, that affect mainly the pediatric population are well described in the literature and that has had an impact on the improvement in overall survival during the past 20 years. RMS in the adult population has a low incidence, therefor the study of RMS in this group is challenging. Pleomorphic RMS is the subtype that mainly affects adults and its biology and genetics are not yet completely understood and described. The risk factors for this tumor and the differences among adults and children is also poorly understood. The treatments for adults that have RMS are not standardized having an impact on the overall survival. Pleomorphic RMS has, compared to other adult sarcomas, poor overall survival. Adult patients with RMS have poor prognosis. The standardization of treatments for the adult population is necessary as maybe new treatments for this specific group. There are new treatment options that are being studied mostly in pediatrics and young adults. Immunotherapy is currently proposed as an important treatment possibility including different techniques like vaccination, antigen-mediated therapy, and immune checkpoints. Even if we have a better understanding of RMS, there are still unanswered questions. The improvements seen in the pediatric population are encouraging, but there is still the need to enhance better therapies for adults with RMS.

Original languageEnglish (US)
JournalCurrent Treatment Options in Oncology
Volume16
Issue number6
DOIs
StatePublished - Jun 16 2015

Keywords

  • Immunotherapy
  • Pleomorphic
  • Rhabdomyosarcoma
  • Sarcoma

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Rhabdomyosarcoma in Adults: New Perspectives on Therapy'. Together they form a unique fingerprint.

  • Cite this

    Ruiz-Mesa, C., Goldberg, J. M., Coronado Munoz, A. J., Dumont, S. N., & Trent, J. (2015). Rhabdomyosarcoma in Adults: New Perspectives on Therapy. Current Treatment Options in Oncology, 16(6). https://doi.org/10.1007/s11864-015-0342-8